Niagen Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAGE and other ETFs, options, and stocks.

About NAGE

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). 

CEO
Robert N. Fried
CEORobert N. Fried
Employees
104
Employees104
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
1999
Founded1999
Employees
104
Employees104

NAGE Key Statistics

Market cap
535.50M
Market cap535.50M
Price-Earnings ratio
26.83
Price-Earnings ratio26.83
Dividend yield
Dividend yield
Average volume
747.37K
Average volume747.37K
High today
$6.71
High today$6.71
Low today
$6.51
Low today$6.51
Open price
$6.56
Open price$6.56
Volume
582.13K
Volume582.13K
52 Week high
$14.69
52 Week high$14.69
52 Week low
$5.16
52 Week low$5.16

Stock Snapshot

The current Niagen Bioscience(NAGE) stock price is $6.71, with a market capitalization of 535.5M. The stock trades at a price-to-earnings (P/E) ratio of 26.83.

As of 2025-12-05, Niagen Bioscience(NAGE) stock has fluctuated between $6.51 and $6.71. The current price stands at $6.71, placing the stock +3.1% above today's low and 0.0% off the high.

Niagen Bioscience(NAGE) shares are trading with a volume of 582.13K, against a daily average of 747.37K.

In the last year, Niagen Bioscience(NAGE) shares hit a 52-week high of $14.69 and a 52-week low of $5.16.

In the last year, Niagen Bioscience(NAGE) shares hit a 52-week high of $14.69 and a 52-week low of $5.16.

People also own

Based on the portfolios of people who own NAGE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.